Clinical Trial: Drug Utilization Study on the Prescribing Indications for Cyproterone Acetate and Ethinyl Estradiol in 5 European Countries

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational



Official Title: Drug Utilization Study on the Prescribing Indications for Cyproterone Acetate and Ethinyl Estradiol in 5 European Countries

Brief Summary:

This study is designed to compile the reasons and specific indications for the prescription of Cyproterone Acetate combined with Ethinyl Estradiol by Health Care Providers. The primary objective of the study is to characterize the prescribing behaviors for Cyproterone Acetate combined with Ethinyl Estradiol in 5 European countries (Austria, Czech Republic, France, the Netherlands, and Spain), including:

  • prescription indications for Cyproterone Acetate combined with Ethinyl Estradiol
  • use of Cyproterone Acetate combined with Ethinyl Estradiol in accordance with the updated label
  • concomitant use of Cyproterone Acetate combined with Ethinyl Estradiol and combined hormonal contraceptives
  • second line treatment with Cyproterone Acetate combined with Ethinyl Estradiol for the indication acne